Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Approval of delisting of Vifor Pharma AG's registered shares: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Approval of delisting of Vifor Pharma AG's registered shares


Regulatory News:



AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR



Vifor Pharma AG (SWX:VIFN) (Vifor) announced today that Vifor has received approval for the delisting of the totality of Vifor's

Press release: Leonteq statement on recent media article and business update
Press release: Leonteq statement on recent media article and business update
Press release: Leonteq statement on recent media article and business update
Sales for the third quarter of 2022

Ad hoc announcement pursuant to Art. 53 LR
Sales for the third quarter of 2022 Ad hoc announcement pursuant to Art. 53 LR
Sales for the third quarter of 2022 Ad hoc announcement pursuant to Art. 53 LR
INFICON to Publish its Third Quarter 2022 Results on Thursday, October 20, 2022
INFICON to Publish its Third Quarter 2022 Results on Thursday, October 20, 2022
INFICON to Publish its Third Quarter 2022 Results on Thursday, October 20, 2022
Invitation to Q3 2022 Trading Update Conference Call
Invitation to Q3 2022 Trading Update Conference Call
Invitation to Q3 2022 Trading Update Conference Call
u-blox AG: Ricoh chooses u-blox GNSS expertise for its new 360-degree camera
u-blox AG: Ricoh chooses u-blox GNSS expertise for its new 360-degree camera
u-blox AG: Ricoh chooses u-blox GNSS expertise for its new 360-degree camera
Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting
Sonova Investor & Analyst Day 2022:
Leading innovation and further expanding our reach
Sonova Investor & Analyst Day 2022: Leading innovation and further expanding our reach
Sonova Investor & Analyst Day 2022: Leading innovation and further expanding our reach
Evolva’s NootkaSHIELDTM insect repellent approved in Hong Kong
Evolva’s NootkaSHIELDTM insect repellent approved in Hong Kong
Evolva’s NootkaSHIELDTM insect repellent approved in Hong Kong
Private Equity Holding AG: Net Asset Value as of September 30, 2022
Private Equity Holding AG: Net Asset Value as of September 30, 2022
Private Equity Holding AG: Net Asset Value as of September 30, 2022
FEMSA completes acquisition of Valora
FEMSA completes acquisition of Valora
FEMSA completes acquisition of Valora
Relief Announces U.S. Launch of PKU GOLIKE
Relief Announces U.S. Launch of PKU GOLIKE
Relief Announces U.S. Launch of PKU GOLIKE
Kapruvia® (Difelikefalin) jetzt in Deutschland für Hämodialysepatient:innen mit CKD-assoziiertem Pruritus erhältlich: https://mms.businesswire.com/media/20191103005014/en/691947/5/VP_logo_rgb.jpg
Kapruvia® (Difelikefalin) jetzt in Deutschland für Hämodialysepatient:innen mit CKD-assoziiertem Pruritus erhältlich


CSL Vifor gab heute die Markteinführung von Kapruvia® zur Behandlung von mäßigem bis schwerem Juckreiz im Zusammenhang mit CKD bei Erwachsenen bekannt, die sich einer Hämodialyse unterziehen.1 Kapr

Rieter and the Johann Jacob Rieter Foundation Sponsor Professorship for Artificial Intelligence at the ZHAW
Rieter and the Johann Jacob Rieter Foundation Sponsor Professorship for Artificial Intelligence at the ZHAW
Rieter and the Johann Jacob Rieter Foundation Sponsor Professorship for Artificial Intelligence at the ZHAW
New IT services and solutions leader emerges in Western Switzerland
New IT services and solutions leader emerges in Western Switzerland
New IT services and solutions leader emerges in Western Switzerland
u-blox AG: u-blox announces explorer kits for product designers needing centimeter-level positioning accuracy
u-blox AG: u-blox announces explorer kits for product designers needing centimeter-level positioning accuracy
u-blox AG: u-blox announces explorer kits for product designers needing centimeter-level positioning accuracy
Evolva business update: Continued good business momentum
Evolva business update: Continued good business momentum
Evolva business update: Continued good business momentum
Valora significantly expands returnable cup system in Switzerland
Valora significantly expands returnable cup system in Switzerland
Valora significantly expands returnable cup system in Switzerland
Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.
Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.
Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.
Comet obtains permanent injunction against XP Power
Comet obtains permanent injunction against XP Power
Comet obtains permanent injunction against XP Power
FEMSA publishes the definitive end result of the public tender offer for Valora – Settlement of the Offer scheduled for Friday, October 7, 2022
FEMSA publishes the definitive end result of the public tender offer for Valora – Settlement of the Offer scheduled for Friday, October 7, 2022
FEMSA publishes the definitive end result of the public tender offer for Valora – Settlement of the Offer scheduled for Friday, October 7, 2022
Burkhalter Group purchases electrical engineering company in Bern
Burkhalter Group purchases electrical engineering company in Bern
Burkhalter Group purchases electrical engineering company in Bern
DKSH’s Sustainability Achievements Awarded With the EcoVadis Gold Rating
DKSH’s Sustainability Achievements Awarded With the EcoVadis Gold Rating
DKSH’s Sustainability Achievements Awarded With the EcoVadis Gold Rating
Meyer Burger seizes opportunity for accelerated growth and plans ordinary capital increase targeting gross proceeds of up to CHF 250 million
Meyer Burger seizes opportunity for accelerated growth and plans ordinary capital increase targeting gross proceeds of up to CHF 250 million
Meyer Burger seizes opportunity for accelerated growth and plans ordinary capital increase targeting gross proceeds of up to CHF 250 million
HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 270.92 as at 30 September 2022
HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 270.92 as at 30 September 2022
HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 270.92 as at 30 September 2022